» Articles » PMID: 17577135

Stem Cell Mechanisms and Paracrine Effects: Potential in Cardiac Surgery

Overview
Journal Shock
Date 2007 Jun 20
PMID 17577135
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Heart disease remains the leading cause of death in the industrialized world. Stem cell therapy is a promising treatment modality for injured cardiac tissue. A novel mechanism for this cardioprotection may include paracrine actions. Cardiac surgery represents the unique situation where preischemia and postischemia treatment modalities exist that may use stem cell paracrine protection. This review (1) recalls the history of stem cells in cardiac disease and the unraveling of its mechanistic basis for protection, (2) outlines the pathways for stem cell-mediated paracrine protection, (3) highlights the signaling factors expressed, (4) explores the potential of using stem cells clinically in cardiac surgery, and (5) summarizes all human stem cell studies in cardiac disease to date.

Citing Articles

Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cell Therapy in Preclinical Models of Sepsis: A Systematic Review and Meta-analysis.

Hum C, Tahir U, Mei S, Champagne J, Fergusson D, Lalu M Stem Cells Transl Med. 2024; 13(4):346-361.

PMID: 38381583 PMC: 11016835. DOI: 10.1093/stcltm/szae003.


miRNAs in Extracellular Vesicles from iPS-Derived Cardiac Progenitor Cells Effectively Reduce Fibrosis and Promote Angiogenesis in Infarcted Heart.

Xuan W, Wang L, Xu M, Weintraub N, Ashraf M Stem Cells Int. 2019; 2019:3726392.

PMID: 31814833 PMC: 6878789. DOI: 10.1155/2019/3726392.


Stem Cell Therapy and Hydrogen Sulfide: Conventional or Nonconventional Mechanisms of Action?.

Jensen A, Drucker N, Olson K, Markel T Shock. 2019; 53(6):737-743.

PMID: 31348146 PMC: 6980464. DOI: 10.1097/SHK.0000000000001420.


Cardiac Progenitors Induced from Human Induced Pluripotent Stem Cells with Cardiogenic Small Molecule Effectively Regenerate Infarcted Hearts and Attenuate Fibrosis.

Xuan W, Wang Y, Tang Y, Ali A, Hu H, Maienschein-Cline M Shock. 2018; 50(6):627-639.

PMID: 29485473 PMC: 6109623. DOI: 10.1097/SHK.0000000000001133.


Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers.

Pati S, Pilia M, Grimsley J, Karanikas A, Oyeniyi B, Holcomb J Shock. 2015; 44(6):505-23.

PMID: 26428845 PMC: 4851225. DOI: 10.1097/SHK.0000000000000482.